Мы используем Cookies Этот веб-сайт использует cookie-файлы, чтобы предлагать вам наиболее актуальную информацию. Просматривая этот веб-сайт, Вы принимаете cookie-файлы.
What NPC is going to understand the question sufficiently to answer yes?
2
Conclusions: NPC patients in Cantonese population have obvious family and territorial clustering.
3
After debating the issue, the NPC will vote on it next week.
4
Conclusion: In our institutional study, NPC presents late and in advanced stage.
5
It is an urgent need to uncover novel treatment targets for NPC.
1
Methods and materials: From 1988 to 1998, 68 patients with nasopharynxcancer received conventional external beam therapy followed by a 3D boost.
2
Purpose: To determine whether the use of 3-dimensional (3D) boost for patients with nasopharynxcancer improves local control and reduces the risk of long-term complications.
Использование термина nasopharyngeal carcinoma на английском
1
Conclusion: Cystatin C levels are associated with the prognosis of nasopharyngealcarcinoma patients.
2
Methods: Fourteen patients with nodal metastases from nasopharyngealcarcinoma were studied.
3
After resection of nasopharyngealcarcinoma was performed, the urinary protein level decreased rapidly.
4
Objective: Patients with nasopharyngealcarcinoma experience highly variable outcomes despite receiving similar therapeutic regimens.
5
Conclusion: VEGF plays an important role in the growth and prognosis of nasopharyngealcarcinoma.
6
Conclusion: Simultaneous boost irradiation radiotherapy is feasible in patients with locally advanced nasopharyngealcarcinoma.
7
One patient each with nasopharyngealcarcinoma and fibrous sarcoma were also treated without success.
8
Maxillary osteosarcomas after irradiation for nasopharyngealcarcinoma do not appear to have been described.
9
During this period, the patient was diagnosed with nasopharyngealcarcinoma.
10
These results suggest the EBV association with BC in an endemic area of nasopharyngealcarcinoma.
11
Methods: Quantitative Polymerase Chain Reaction was performed on nasopharyngealcarcinoma and their paired normal tissues.
12
We conducted skin-prick allergen tests on 22 patients with newly diagnosed but not-yet-treated nasopharyngealcarcinoma.
13
We aimed to compare these frameworks in nasopharyngealcarcinoma.
14
We report a very rare case of recurrent nasopharyngealcarcinoma with local involvement of lacrimal sac.
15
Background: Circulating Epstein-Barr virus DNA is a predictor of disease recurrence in patients with nasopharyngealcarcinoma.
16
The primary treatment for nasopharyngealcarcinoma is radiotherapy.